Robert Schneider

F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria.

Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany.

Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris.

NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.

Gimv Life Sciences (Gimv-LS) is the venture capital division of Belgium's Gimv NV (XB: GIMB), an investment firm founded in 1980. Based in Antwerp, Gimv-LS manages a variety of funds which focus on investing in European companies in the life sciences / biotech sector, including the Biotech Fonds Vlaanderen, which was established at the request of the Flemish Region to provide venture capital to existing and start-up medium and large-sized companies in the Flemish biotechnology sector.

Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France.

Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA.

Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany.

iTAC Software AG provides software solutions. It offers serves the automotive industry, medical technologies, metal processing industry, energy and utilities industry, and electronics industry. The firm's products are manufacturing execution system (MES) suite, embedded systems, smart devices and enterprise framework. The company was founded by Dieter Meuser, Volker Burch and Christine Lahnstein in 1998 and is headquartered in Montabaur, Germany.

Ambu Innovation GmbH engages in the development and distribution of single-use and light-weight robotically-assisted high definition endoscopy products in the field of gastroenterology and gastro-intestinal surgery. Its products include invendoscope SC210, invendo ScopeController, and invendo SPU E210. The company was founded in 1992 and is headquartered in Kissing, Germany.

Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany.

Greencoat Capital LLP (Greencoat Capital) is a private equity firm founded by Richard Charles Henry Nourse in 2009. The firm headquartered in London.

SELC Ireland Ltd. manufactures electronic controllers for street lighting. Its products include photocells, ballasts, gear tray, LED drivers, time switches, and NEMA sockets. The firm's solutions optimize the switching on and off and dimming of street lights, and can adjust intensity of lighting based on prevailing conditions. The company was founded by Sean Noone in 1982 and is headquartered in Connacht, Ireland.

Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany.

Rigontec GmbH provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The firm develops a compound stimulating the immune receptor retinoic acid-inducible gene. The company was founded by Annegret de Baey-Diepolder, Gunther Hartmann, Anna Schwickart, Marcel Renn, Christine Schuberth-Wagner and Veit Hornung in 2014 and is headquartered in Munich, Germany.

NetXtra Ltd. engages in the provision of digital services. It offers strategy, integration, ecommerce, digital marketing, and support. The company was founded by Robert William Schrimpff and Simon Hardingham in 1995 and is headquartered in Bury St. Edmunds, the United Kingdom.

leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany.

MANTA Instruments, Inc., engages in the production of scientific instruments that characterize nanoparticles. It focuses on ViewSizer 3000 product which performs individual particle analysis simultaneously on particles ranging in size. The company was founded in 2014 and is headquartered in San Diego, CA.

Charité Research Organisation GmbH is a contract research organization that helps clients move development projects from first time in human to proof of concept as quickly and efficiently as possible. The private company is based in Berlin, Germany and was founded in 2005 by Frank Wagner, who has been the CEO since then. Charité Research Organisation offers scientific and regulatory consultancy, protocol development, routine laboratory, biomarker laboratory, imaging, project management, monitoring, data management, biostatistics, and medical writing services. The German company also provides world-leading patient and healthy volunteer recruitment capabilities and delivers the best value solution for early clinical development.

Virometix AG is a Swiss biotechnology company that focuses on developing vaccines and immunotherapeutic drugs for the prevention and treatment of infections and cancer. Virometix is based in Schlieren, CH. The private company's mission is to address the growing medical need for vaccines to combat infectious and chronic human diseases. The company was founded by John Anthony Robinson, and the CEO is Anna Sumeray.

3B Pharmaceuticals GmbH is a German biotechnology company that specializes in developing targeted radiopharmaceutical drugs and diagnostics for oncology indications with a high unmet medical need. The company is based in Germany. The private company is a leader in peptide discovery and optimization, with a technology platform that extends from hit identification to early clinical development. The company is owned by its founders and management. 3BP was founded in 2008 by a team of renowned experts in peptide drug discovery and nuclear medicine from Bern and Basel. The company was founded in 2008 by Jochen Knolle. The CEO is Ulrich Reineke.

TVM V LSV Beteiligungsgesellschaft mbH provides investment services. The private company is based in Munich, Germany. The CEOs are Stefan Fischer, Josef Moosholzer. The German company was founded in 2001.

TVM IV Beteiligungsgesellschaft mbH provides professional, scientific, and technical services. The private company is based in Munich, Germany. The CEOs are Stefan Fischer, Josef Moosholzer. The German company was founded in 2000.

Part of TVM Capital GmbH, TVM Life Science Management GmbH provides management services. The company is based in Munich, Germany. The CEO of the German company is Stefan Fischer.